Hainv Gao

机构：Zhejiang Shuren University · ORCID：0000-0003-4590-9181

发表论文 114 篇 · 总被引 11080 次 · h-index 36

代表论文

• Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions (2023 · Clinical Infectious Diseases · 被引 103)
• Global emergence of Carbapenem-resistant Hypervirulent Klebsiella pneumoniae driven by an IncFIIK34 KPC-2 plasmid (2025 · EBioMedicine · 被引 50)
• Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study (2023 · The Lancet Infectious Diseases · 被引 48)
• International Epidemiology of Carbapenemase-Producing Escherichia coli (2023 · Clinical Infectious Diseases · 被引 36)
• Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial (2024 · Clinical Microbiology and Infection · 被引 16)
• Blood biomarkers of hepatocellular carcinoma: a critical review (2024 · Frontiers in Cell and Developmental Biology · 被引 13)